Feeling the pressure.

Similar (but kind of opposite) to the increase in adoption of hypofractionation after peers do so, this retrospective cohort study demonstrates that physicians who began using bevacizumab between 2007-2010 are much more likely to have peer physicians who were earlier adopters of bev. | Keating, JAMA Netw Open 2020